Bleomycin: Revival of an old drug

General Pharmacology

Volumn 27, Issue 5, 1996, Pages 745-748

  Mir, L M ^a   Tounekti, O ^a   Orlowski, S ^b  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b CEA SACLAY   (France)

Author keywords

Bleomycin; C ytotoxicity; Electrochemotherapy; Electropermeabilization; Review

Indexed keywords

BLEOMYCIN; CELL MEMBRANE PROTEIN; DNA; NUCLEIC ACID;

ANIMAL CELL; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; CANCER CHEMOTHERAPY; CELL LEVEL; CELL MEMBRANE; CLINICAL TRIAL; CYTOTOXICITY; DIFFUSION; DNA BINDING; DRUG MECHANISM; DRUG UPTAKE; ELECTROCHEMOTHERAPY; ELECTROPORATION; GENOTOXICITY; HUMAN; LUNG FIBROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW; SOLID TUMOR;

EID: 0030198955     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-3623(95)02101-9     Document Type: Review

References (30)

1. Belehradek J. Jr., Orlowski S., Poddevin B., Paoletti C. and Mir L. M. (1991) Electrochemotherapy of spontaneous mammary tumours in mice. Eur. J. Cancer 27, 73-76.
2. Belehradek J. Jr., Orlowski S., Ramirez L. H., Pron G., Poddevin B. and Mir L. M. (1994) Electropermeabilization of cells in tissues assessed by the qualitative and quantitative electroloading of bleomycin. Biochim. Biophys. Acta 1190, 155-163.
3. Belehradek M., Domenge C., Luboinski B., Orlowski S., Belehradek J. Jr. and Mir L. M. (1993) Electrochemotherapy, a new antitumour treatment: first clinical phase I-II trial. Cancer 72, 3694-3700.
4. Carter B. J., de Vroom E., Long E. C., van der Marel G. A., van Boom J. H. and Hecht S. M. (1990) Site-specific cleavage of RNA by Fe(II)·bleomycin. Proc. Natl. Acad. Sci. USA 87, 9373-9377.
5. D'Andrea A. D. and Haseltine W. A. (1978) Sequence specific cleavage of DNA by the antitumour antibiotics neocarzinostatin and bleomycin. Proc. Natl. Acad. Sci. USA 75, 3608-3612.
6. Dorr, R. T. (1992) Bleomycin pharmacology: mechanisms of action and resistance, and clinical pharmacokinetics. Semin. Oncol. 19 (supp5), 3-8.
7. Heller R., Jaroszeski M. J., Leo-Messina J., Perrot R., Van Voorhis N., Reintgen D. and Gilbert R. (1995) Treatment of B16 mouse melanoma with the combination of electropermeabilization and chemotherapy. Bioelectrochem. Bioenerg. 36, 83-87.
8. Kuo M. T. (1981) Preferential damage of active chromatin by bleomycin. Cancer Res. 41, 2439-2443.
9. Lazo J. S., Schisselbauer J. C., Herring G. M. and Kennedy K. A. (1990) Involvement of the cellular vacular system with the cytotoxicity of bleomycin like agents. Cancer Comm. 2, 81-86.
10. Lyman S., Ujjani B., Renner K., Antholine W., Petering D. H., Whetstone J. W. and Knight J. M. (1986) Properties of the initial reaction of bleomycin and several of its metal complexes with Ehrlich cells. Cancer Res. 46, 4472-4478.
11. Mir L. M., Banoun H. and Paoletti C. (1988) Introduction of definite amounts of nonpermeant molecules int living cells after electropermeabilization: direct access to the cytosol. Exp. Cell Res. 175, 15-25.
12. Mir L. M., Orlowski S., Belehradek J. Jr. and Paoletti C. (1991) Electrochemotherapy: potentiation of antitumour effect of bleomycin by local electric pulses. Eur. J. Cancer 27, 68-72.
13. Mir L. M., Roth C., Orlowski S., Quintin-Colonna F., Fradelizi D., Belechradek J. Jr. and Kourilsky P. (1995a) Systemic antitumor effects of electrochemotherapy combined with histoincompatible cells secreting interleukin-2. J. Immunother. 17, 30-38.
14. Mir L. M., Orlowski S., Belehradek J. Jr., Teissié J., Rols M. P., Sersa G., Miklavcic D., Gilbert R. and Heller R. (1995b) Biomedical applications of electric pulses with special emphasis on antitumour electrochemotherapy. Bioelectrochem. Bioenerg. 38, 203-207.
15. Orlowski S., Belehradek J. Jr., Paoletti C. and Mir L. M. (1988) Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs. Biochem. Pharmac. 37, 4727-4733.
16. Orlowski S. and Mir L. M. (1993) Cell electropermeabilization: a new tool for biochemical and pharmacological studies. Biochem. Biophys. Acta 1154, 51-63.
17. Poddevin B., Orlowski S., Belehradek J. Jr. and Mir L. M. (1991) Very high cytotoxicity of bleomycin introduced into the cytosol of cells in culture. Biochem. Pharmac. 42(S), 67-75.
18. Povirk L. F., Wübker W., Köhnlein W. and Hutchinson F. (1977) DNA double-strand breaks and alkali-labile bonds produced by bleomycin. Nucleic Acids Res. 4, 3573-3580.
19. Povirk L. F., Han Y. H. and Steighner R. J. (1989) Structure of bleomycin-induced DNA double-strand breaks: predominance of blunt ends and single-base 5′ extensions. Biochemistry 28, 5808-5814.
20. Povirk L. F. and Austin M. J. F. (1991) Genotoxicity of bleomycin. Mutation Res. 257, 127-143.
21. Pron G., Belehradek J. Jr., and Mir L. M. (1993) Identification of a plasma membrane protein that specifically binds bleomycin. Biochem. Biophys. Res. Commun. 194, 333-337.
22. Pron G., Belehradek J. Jr., Orlowski S. and Mir L. M. (1994) Involvement of the membrane bleomycin-binding sites in the bleomycin cytotoxicity. Biochem. Pharmac. 48, 301-310.
23. 2 with HeLa cells. Cancer Res. 44, 1541-1546.
24. Salford L. G., Persson, B. R. R., Brun A., Ceberg C. P., Kongstad P. C. and Mir L. M. (1993) A new brain tumour therapy combining bleomycin with in vivo electropermeabilization. Biochem. Biophys. Res. Commun. 194, 938-943.
25. Sebti S. M., Mignano J. E., Jani J. P., Srimatkandada S. and Lazo J. S. (1989) Bleomycin Hydrolase: Molecular cloning, sequencing and biochemical studies reveal membership in the cysteine proteinase family. Biochemistry 28, 6544-6548.
26. Sersa G., Cemazar M., Miklavcic D. and Mir L. M. (1994) Electrochemotherapy: variable anti-tumour effect on different tumour models. Bioelectrochem. Bioenerg. 35, 23-27.
27. Stubbe J. and Kozarich J. W. (1987) Mechanisms of bleomycin-induced DNA degradation. Chem. Rev. 87, 1107-1136.
28. Tounekti O., Belehradek J. Jr. and Mir L. M. (1995) Relationships between DNA fragmentation, chromatin condensation and changes in flow cytometry profiles detected during apoptosis. Exp. Cell Res. 217, 506-516.
29. Tounekti O., Pron G., Belehradek J. Jr. and Mir L. M. (1993) Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized. Cancer Res. 53, 5462-5469.
30. Umezawa H., Maeda K., Takeuchi T. and Okami Y. (1966) New antibiotics, bleomycin A and B. J. Antibiot (Tokyo) Ser. A 19, 200-209.